Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 29;9(9):1988.
doi: 10.3390/cells9091988.

The Role of Exosomes in the Crosstalk between Adipocytes and Liver Cancer Cells

Affiliations
Review

The Role of Exosomes in the Crosstalk between Adipocytes and Liver Cancer Cells

Leslimar Rios-Colon et al. Cells. .

Abstract

Exosomes are membrane-bound extracellular vesicles (EVs) that transport bioactive materials between cells and organs. The cargo delivered by exosomes can alter a wide range of cellular responses in recipient cells and play an important pathophysiological role in human cancers. In hepatocellular carcinoma (HCC), for example, adipocyte- and tumor-secreted factors contained in exosomes contribute to the creation of a chronic inflammatory state, which contributes to disease progression. The exosome-mediated crosstalk between adipocytes and liver cancer cells is a key aspect of a dynamic tumor microenvironment. In this review, we summarize the role of increased adiposity and the role of adipocyte-derived exosomes (AdExos) and HCC-derived exosomes (HCCExos) in the modulation of HCC progression. We also discuss recent advances regarding how malignant cells interact with the surrounding adipose tissue and employ exosomes to promote a more aggressive phenotype.

Keywords: adipocyte exosomes; adipocytes; cell signaling; exosomal cargo; exosomes; hepatocellular carcinoma; obesity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Adipogenesis and different types of adipose tissue. Adipocytes can be divided into three different types depending on their origin, metabolic activity and morphological features. These are brown (BAT), white (WAT) and beige adipocytes. Mesenchymal precursors are committed and differentiate into pre-adipocytes, then further mature into adipocytes of a particular lineage influenced by various transcription factors, cell to cell communication, and extracellular signaling. WATs can also be transformed into beige adipocytes and vice versa, influenced by energy availability, temperature and extracellular signaling.
Figure 2
Figure 2
Exosome biogenesis and release. Exosomes are generated by the endocytic pathway activated by local signaling that culminates in its exocytosis into the extracellular microenvironment. Inward budding and complete invagination results in the formation of MVBs and the encapsulation of RNAs, cytosolic proteins, metabolites, hormones and bioactive lipids. After further processing, a fusion of the membrane facilitates the release of mature exosomes into extracellular space. Alternatively, they may also form lysosomes that are slated for degradation.
Figure 3
Figure 3
Adipocyte and HCC exosomes crosstalk leading to increased tumor progression. Exosomes released by both adipocytes (AdExos) and HCC (HCCExos) have unique intracellular components, including a wide variety of mRNAs, microRNAs, lncRNAs, circRNAs, lipids, metabolites and proteins. These intracellular components are utilized as autocrine or paracrine communicators to induce pathways that result in increased cell proliferation, angiogenesis, invasion, and other hallmarks of malignancy.

References

    1. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2019. CA Cancer J. Clin. 2019;69:7–34. doi: 10.3322/caac.21551. - DOI - PubMed
    1. Perumpail B.J., Khan M.A., Yoo E.R., Cholankeril G., Kim D., Ahmed A. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World J. Gastroenterol. 2017;23:8263–8276. doi: 10.3748/wjg.v23.i47.8263. - DOI - PMC - PubMed
    1. Golabi P., Paik J., Reddy R., Bugianesi E., Trimble G., Younossi Z.M. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States. BMC Gastroenterol. 2019;19:56. doi: 10.1186/s12876-019-0972-6. - DOI - PMC - PubMed
    1. Osna N.A., Donohue T.M., Jr., Kharbanda K.K. Alcoholic Liver Disease: Pathogenesis and Current Management. Alcohol Res. 2017;38:147–161. - PMC - PubMed

Publication types